On July 12, 2021, WDpharma received the Notice of Approval for Drug Clinical Trial from the National Medical Products Administration, and the WD-1603 project has entered into Phase II clinical trials.
Tel：86-021-68599718
E-mail：WDpharma@wdpharma.com
Address：720 Cailun Road, Suite 403,Building 1, Zhangiiang Hi-Tech Park, Pudong New District, Shanghai, China（R&D Center）
Zip code：201203
